Patrick J. Heron, Director, 10% Owner at Mirum Pharmaceuticals, Inc. (MIRM), bought 295,982 shares at $26.25 ($7.8M) on 2023-08-31, disclosed to the SEC on 2023-09-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.25 | 147,991 | $3.9M | 50.0% |
| 2 | $26.25 | 147,991 | $3.9M | 50.0% |
| Total | $26.25 avg | 295,982 | $7.8M | 100% |
| Filing → |
| ARQT | BUY | 2025-06-06 | $30K | — | Filing → |
| ARQT | BUY | 2025-05-23 | $69K | — | Filing → |
| ARQT | BUY | 2025-05-19 | $34K | — | Filing → |